These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9795392)

  • 1. Development of engineered vaccines effective against structurally related bacterial superantigens.
    Ulrich RG; Olson MA; Bavari S
    Vaccine; 1998 Nov; 16(19):1857-64. PubMed ID: 9795392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G; Levy R; Hillman D; Kaempfer R
    Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock.
    Arad G; Hillman D; Levy R; Kaempfer R
    J Leukoc Biol; 2001 Jun; 69(6):921-7. PubMed ID: 11404377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A structural and functional comparison of staphylococcal enterotoxins A and C2 reveals remarkable similarity and dissimilarity.
    Schad EM; Papageorgiou AC; Svensson LA; Acharya KR
    J Mol Biol; 1997 Jun; 269(2):270-80. PubMed ID: 9191070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope mapping of neutralizing TSST-1 specific antibodies induced by immunization with toxin or toxoids.
    Gampfer JM; Samstag A; Waclavicek M; Wolf HM; Eibl MM; Gulle H
    Vaccine; 2002 Nov; 20(31-32):3675-84. PubMed ID: 12399195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular docking of superantigens with class II major histocompatibility complex proteins.
    Olson MA; Cuff L
    J Mol Recognit; 1997; 10(6):277-89. PubMed ID: 9770652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad-spectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptide.
    Arad G; Hillman D; Levy R; Kaempfer R
    Immunol Lett; 2004 Feb; 91(2-3):141-5. PubMed ID: 15019282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations affecting the superantigen activity of staphylococcal enterotoxin B.
    Briggs C; Garcia C; Zhang L; Guan L; Gabriel JL; Rogers TJ
    Immunology; 1997 Feb; 90(2):169-75. PubMed ID: 9135543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of staphylococcal enterotoxin I (SEI) in complex with a human major histocompatibility complex class II molecule.
    Fernández MM; Guan R; Swaminathan CP; Malchiodi EL; Mariuzza RA
    J Biol Chem; 2006 Sep; 281(35):25356-64. PubMed ID: 16829512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation.
    Tiedemann RE; Fraser JD
    J Immunol; 1996 Nov; 157(9):3958-66. PubMed ID: 8892628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen.
    Jardetzky TS; Brown JH; Gorga JC; Stern LJ; Urban RG; Chi YI; Stauffacher C; Strominger JL; Wiley DC
    Nature; 1994 Apr; 368(6473):711-8. PubMed ID: 8152483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells.
    Wahlsten JL; Mills CD; Ramakrishnan S
    J Immunol; 1998 Dec; 161(12):6761-7. PubMed ID: 9862706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A.
    Bavari S; Dyas B; Ulrich RG
    J Infect Dis; 1996 Aug; 174(2):338-45. PubMed ID: 8699064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines.
    Lowell GH; Colleton C; Frost D; Kaminski RW; Hughes M; Hatch J; Hooper C; Estep J; Pitt L; Topper M; Hunt RE; Baker W; Baze WB
    Infect Immun; 1996 Nov; 64(11):4686-93. PubMed ID: 8890226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcal enterotoxins A and B share a common structural motif for binding class II major histocompatibility complex molecules.
    Ulrich RG; Bavari S; Olson MA
    Nat Struct Biol; 1995 Jul; 2(7):554-60. PubMed ID: 7664123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bacterial superantigen and superantigen-like proteins.
    Fraser JD; Proft T
    Immunol Rev; 2008 Oct; 225():226-43. PubMed ID: 18837785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
    Karp DR; Long EO
    J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1.
    Buonpane RA; Moza B; Sundberg EJ; Kranz DM
    J Mol Biol; 2005 Oct; 353(2):308-21. PubMed ID: 16171815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1.
    Kim J; Urban RG; Strominger JL; Wiley DC
    Science; 1994 Dec; 266(5192):1870-4. PubMed ID: 7997880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.